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Oxidative stress and inflammation are DNA instability factors for rheumatoid arthritis 
(RA) patients. The aims of this study were to evaluate cytogenetic alterations in 
Peripheral Blood Lymphocytes (PBL) in two groups of RA patients: the early and the 
long-term RA group; and to examine potential of concomitant treatment with 
Methotrexate (MTX) and Dry olive leaf extract (DOLE) against cytogenetic damage in 
RA patients after a 3-weeks treatment. A total of 32 RA patients and 10 healthy 
individuals were included. RA patients were equally divided into four groups: two 
groups with early phase RA (one treated with MTX alone, the other in combination with 
DOLE); and two long-term phase RA groups (group with active disease and group with 
low disease activity)-both treated with MTX and DOLE combination.  PBL cultures 
were screened for chromosome aberrations and micronuclei frequencies. Significantly 
increased frequencies of micronuclei were shown in active phase RA disease (both early 
and long-term) but not in the group with low disease activity, as compared to controls. 
Chromosome aberrations were detected for all 4 RA groups. The highest frequencies of 
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micronuclei and chromosome aberrations were found in the long-term active RA group. 
After 3 weeks-treatment, there were no significant decrease of the micronuclei 
frequencies compared to baseline, although they were reduced in all RA groups, except 
for the group with the long-term active disease. High level of cytogenetic damage in RA 
patients was concordant with duration and activity of the RA disease. At 3 weeks of 
therapy, neither the combined treatment (MTX+DOLE), nor MTX alone did not affect 
the frequency of micronuclei formation. 
Keywords: Dry olive leaf extract, DNA damage, Micronuclei, Chromosome 
aberrations, Rheumatoid arthritis. 
 
INTRODUCTION 
Rheumatoid arthritis (RA) is one of the most prevalent inflammatory rheumatic disease, 
with the reported prevalence in adults of 0,5%-1%, being increased with age (ZLATKOVIC-
SVENDA et al., 2014).
 
It is characterized by ongoing synovial joints inflammation and oxidative 
stress, leading to the affected cells genomic instability (EMERIT et al., 1996). Genomic instability 
is defined as an increased genomic alterations tendency. Pathological consequences of genomic 
instability can accumulate during disease development, manifesting in the form of chromosome 
instability (YUROV et al., 2009). Certain cytogenetic alterations in RA patients’ lymphocytes and 
fibroblasts have already been observed, considered as associated with lymphocyte activation 
(KARAMAN et al., 2011; KINNE et al., 2001). Reactive oxygen species (ROS), released at the site 
of inflammation by phagocytic cells, may enter surrounding cells and react with nuclear DNA 
(BASHIR et al., 1993). In the presence of activated phagocytes, in vitro cell cultures have 
displayed mutagenic and carcinogenic DNA lesions (REUTER et al., 2010).
 
As already reported, 
peripheral blood lymphocytes (PBL) and fibroblasts culture analyses in RA patients revealed the 
chromosomal aberrations presence and increased number of micronuclei (KARAMAN et al., 2011; 
KINNE et al., 2001). RA patients’ lymphocytes have shown increased DNA fragmentation levels, 
resulting from unrepaired DNA damage (BASHIR et al., 1993; KARAMAN et al., 2011). Knowing 
the well-established link between genomic damage and neoplastic transformation, inflammation 
in RA patients could also promote carcinogenesis (CIOŁ KIEWICZ et al., 2008). 
Methotrexate (MTX) is a known clastogenic agent in mammalian cells, used as a 
standard therapeutic agent for RA patients. Combination therapies of MTX and bioactive natural 
compounds are being extensively explored nowadays, aiming to maintain positive effect of the 
inflammation reduction and at the same time reduce the long-term MTX usage adverse effects 
during the course of the RA disease (LAEV and SALAKHUTDINOV, 2015; MADHYASTHA et al., 
2008). Varieties of complementary and alternative medicines were explored so far as potential 
treatments for rheumatoid arthritis. Dry olive leaf extract (DOLE) is a polyphenol-rich natural 
product of olive tree (Olea europaea L.) with proved anti-inflammatory, antigenotoxic and 
antioxidant effect in vivo and DNA-protective abilities in vitro (SILVA et al., 2006; MILJKOVIĆ et 
al., 2009; ÇOBAN et al., 2014;  ĈABARKAPA et al., 2014; ŽUKOVEC TOPALOVIĆ et al., 2015). When 
summarizing these actions, it is a promising agent as the RA supportive therapy.  
We have previously demonstrated increased levels of primary DNA damage in both 
early phase and long-term phase RA patients (ĈABARKAPA et al., 2016). It was also shown that a 
3-weeks supplementation with DOLE combined with MTX could significantly reduce DNA 
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damage levels in early phase RA patients, but not in patients with the established, long-term 
disease (ĈABARKAPA et al., 2016). Adding to our previous research, the aim of the present study 
was to determine whether a 3-week dry olive leaf extract supplementation combined with 
methotrexate could affect the peripheral blood lymphocytes frequencies of micronuclei 
formation in newly-diagnosed RA patients and long-term RA patients, both in active disease and 
with low disease activity. The second aim was to examine the association between cytogenetic 
alterations and both disease duration and disease activity RA patients, by comparing long-term 
and newly-diagnosed disease patients. Prior the combined treatment was introduced, background 
(baseline) levels of cytogenetic alterations were determined by micronucleus (MN) test and 
chromosome aberrations assay (CAs) in PBL cultures.  
 
 
MATERIALS AND METHODS 
Participants 
Thirty-two patients (25 females and 7 males) diagnosed with RA, participated in this 
study with a mean (SD) age of 65.1 (11.2) years. Ten healthy individuals (7 females and 3 males) 
aged 54.22 (9.09) years, were enrolled as non-treated controls with no history of chronic illness. 
As part of a pilot study, patients were recruited on a voluntary basis at the Institute of 
Rheumatology, University of Belgrade, Faculty of Medicine, Serbia. This study was approved by 
the local Ethics Committee (Institute of Rheumatology, Belgrade, Serbia), prior to study 
initiation. The study was performed in agreement with the Declaration of Helsinki and 
participants’ informed consents were obtained. 
 
Blood sampling 
Blood samples were collected from each donor in the morning, before the meal, by 
venipuncture from the basilic vein (at the beginning of the treatment and on the 21
st
 day). The 
blood amount of 5 mL added with heparin as anticoagulant was taken to set up the whole 
peripheral blood cultures for cytogenetic analyses. Another 15 mL of blood was taken for routine 
clinical disease activity checking.  
 
Investigated groups 
The study comprised four experimental RA groups and one control group. Patients were 
recruited to experimental groups with regard to the activity of their RA disease, as assessed with 
disease activity of 28 joints (DAS28) score. DAS28 score is a commonly used score for disease 
activity evaluation in RA patients. It is calculated by designated physician, according to The 
American College of Rheumatology criteria, including the five following components: tender 
joint count out of 28 joints, swollen joint count out of 28 joints, Patient Global Health visual 
analogue scale (VAS), Physician Global Health visual analogue scale (VAS) and one laboratory 
parameter. Since we have used two laboratory parameters: the erythrocyte sedimentation rate 
(ESR) and C-reactive protein (CRP), we have calculated DAS28-ESR and DAS28-CRP 
(HOCHBERG et al., 1992; SOKKA, 2003).
 
 Disease activity was set with regard to the achieved 
DAS28-ESR score as generally agreed, as: DAS28 >5.1 - high disease activity, DAS28 <3.2 - 
low disease activity and DAS28 <2.6 -remission (HOCHBERG et al., 1992).  
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Experimantal groups were: 
EAc MTX – early active phase patients with RA, newly-diagnosed, started to be treated with 
MTX alone at the beginning of the study (n=8),  
EAc MTX+DOLE – early active phase patients with RA, newly-diagnosed, started to be treated 
with MTX in combination with DOLE at the beginning of the study (n=8),  
LtLa MTX+DOLE – long-term phase RA patients with low disease activity (DAS 28 ≤ 3.2), 
diagnosed with RA for more than six months, treated with MTX continuously for at least 6 
months prior to this study initiation (n=8). 
LtAc MTX+DOLE – long-term phase RA patients with active disease (DAS 28>3.2), diagnosed 
with RA at least six months before, continuously treated with MTX for at least 6 months prior to 
this study initiation (n=8). 
 
Treatment 
For the early active RA patients, Methotrexate was introduced at the beginning of the 
study according to disease activity and in accordance with the physicians’  recommended 
guidelines (10-15 mg/week). Long-term RA patients were on a stabile MTX dose for at least 6 
months before being included in the study. Dry olive leaf extract (DOLE) was introduced at the 
beginning of the study and patients were instructed to take two capsules twice daily (total 760 
mg/day). Laboratory parameters collected at the clinic were: serum C-reactive protein (CRP), 
erythrocyte sedimentation rate (ESR), fibrinogen and rheumatoid factor (RF). All other 
parameters were determined as described in Methods. 
 
Olive leaf extract 
Dry olive leaf extract was purchased from Galenika a.d., Belgrade, Serbia and was used 
in this study in a form of capsule crude extract. Each capsule contained 190 mg of a dry 
powdered extract, manufactured by the Frutarom Switzerland Ltd. (Wadenswil, Switzerland). 
The extract was produced applying an ethanol (80% m/m) extraction procedure from the dried 
leaves of Olea europaea L. and standardized to 18-26% of oleuropein. HPLC analysis revealed a 
complex mixture of phenolic compounds: oleuropein (19.8%), luteolin-7-O-glucoside (0.04%), 
apigenine-7-O-glucoside (0.07 %), quercetin (0.04%) and 0.02% of caffeic acid (DEKANSKI et 
al., 2009). 
 
Chromosome aberrations analysis 
Peripheral blood lymphocytes from whole blood were cultivated in 10 mL of RPMI 
1640 medium with HEPES and L-glutamine (Capricorn Scientific, Ebsdorfergrund, Germany), 
10% of fetal calf serum (Capricorn Scientific, Ebsdorfergrund, Germany), 10 mg/mL antibiotics 
(penicillin+streptomycin; Sigma Aldrich, United Kingdom) and 2% of phytohemagglutinin 
(PHA-M, Capricorn Scientific, Ebsdorfergrund, Germany). Duplicate cultures for each patient 
were grown for 72 hours at 37 ºC. Colchicine (Sigma Aldrich, United Kingdom) was added to a 
culture medium in concentration of 0.1 μg/mL, 2 hours before the end of cultivation period, to 
obtain metaphases. At the end of cultivation period of 72 hours cultures were centrifugated and 
cells were resuspended and exposed to hypotonic treatment (0.075 M KCl). After that, cells were 
fixed three times with methanol and acetic acid fixative (3:1) and each fixation was followed by 
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centrifugation. Cells were resuspended in 1 mL of fixative after the last centrifugation, and 
dropped using a pipette onto cooled wet microscopic slides. Slides were dried by passage over 
the flame and stained with 4% Giemsa dye for 15 min. The procedure was done according to the 
method described by VERMA and BABU (1989). For each person 50 metaphases were analyzed. 
Metaphases were screened for numerical and structural aberrations. Acrocentric chromosomes 
associations (AA) and premature centromere division (PCD) frequencies were also noted as 
cytogenetic alterations. The associations between the short arms of acrocentric chromosomes, 
also reported in the literature as satellite associations, are known as cytogenetic endpoint to 
adverse effects in cells (CARADONNA et al., 2015). Mitotic configurations consistent in split 
centromeres and splayed chromatids in all or most of the chromosomes or premature centromere 
division (PCD) have been described as evidence of a functional cell cycle impairment (CORONA-
RIVERA et al., 2005). Alteration of the sequence of centromere separation or premature 
centromere division has been found to be significantly higher in populations exposed to various 
xenobiotics, especially cytostatics that can alter the stability of chromosomes and lead to 
aneuploidy (BAJIC et al., 2007). In order to investigate the chromosomal damage in RA patients, 
frequencies and types of chromosomal aberration were observed and expressed for all groups of 
patients.  
 
Micronucleus assay 
For micronuclei analysis, 0.5 mL of whole blood was added to 5 mL of culture medium. 
The duplicate cultures were set up for each patient and were incubated at 37˚ C for 72 h. A 50 
μL of cytochalasin B from stock solution (6 mg/mL; Sigma Aldrich, United Kingdom) was 
added to each culture, after 44 h of cultivation to prevent cytokinesis and obtain binucleated 
cells. After 72 hours, the cells were separated from the medium by centrifugation, treated with 
hypotonic solution 0.075 M KCl for 3 min at 37°C and fixed three times in 3:1 methanol and 
acetic acid. Cells were dropped onto microscopic slides, air dried at room temperature and 
stained with 2% Giemsa dye for 10 min. Around 1000 binucleated cells (mean ± SD = 
1002.73±8.45, range = 983–1021) from each subject were screened for the presence of MN 
according to the criteria for the identification described by FENECH (1993). Frequency of cells 
with micronuclei, nuceloplasmic bridges and nuclear buds was calculated and expressed for all 
patients in every of the RA patients groups.  
 
Statistical analysis 
Data were expressed as frequencies for chromosome aberration analysis and 
micronucleus test. The Man Whitney U test was used for differences between groups with regard 
to the examined parameters. The level of significance was set at P<0.05. Statistical analyses 
were performed by using the Graph Pad Prism 5.0 Software (California, USA). 
 
RESULTS 
Clinical and laboratory parameters for RA experimental groups are given in Table 1. All 
groups of patients had baseline DAS 28 of >3.2, indicating moderate to high disease activity, 
except for the LtLa group were disease activity was low. Laboratory parameters, CRP, ESR and 
fibrinogen indicated higher level of inflammation in LtAc MTX+DOLE as compared to both the 
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early phase groups (EAc MTX and EAc MTX+DOLE), and to LtLa MTX+DOLE group, the 
latter being presented as the group with the lowest inflammation. There were no observed 
significant differences between the two early phase RA groups with regard to DAS 28-ESR and 
DAS 28-CRP, whereas those parameters were significantly lower in both long-term RA groups, 
as compared to the early phase groups. 
 
Table 1. Clinical characteristics of the rheumatoid arthritis patients groups  
Groups Early phase RA patients Long term RA patients 
Clinical parameters EAc 
MTX 
n=8 
EAc  
MTX+DOLE 
n=8 
LtLa 
MTX+DOLE 
n=8 
LtAc 
MTX+DOLE 
n=8 
Disease duration (years) <1 <1 13.0 (11.3) 11.4 (10.2) 
Symptom onset (years) 0.5 (0.2) 0.7 (0.6) 12.3 (11.9) 14.1 (11.1) 
Positive RF, No (%) 6 (75) 7 (87.5) 8 (100) 9 (100) 
DAS28- ESR score 5.6 (0.7) 5.6 (0.9) 2.8 (0.9) 5.2 (0.6) 
DAS28- CRP score 4.7 (0.6) 5.1 (0.7) 2.1 (0.8) 4.3 (0.8) 
Laboratory parameters     
Serum CRP (mg/L) 3.3 (3.7) 9.8 (8.0) 3.1 (2.2) 12.2 (5.6) 
Fibrinogen (g/L) 4.1 (0.9) 4.5 (1.3) 3.9 (1.2) 5.4 (0.6) 
ESR (mm/hr) 25. 0 (13.4) 31.1 (15.3) 18.9 (8.3) 38.9 (14.8) 
Values are presented as mean (standard deviation, SD), unless otherwise specified. DAS 28, Disease Activity Score 
comprising of 28 tender and swollen joints count, based on current C-reactive protein (DAS 28-CRP) OR erythrocyte 
sedimentation rate (DAS 28-ESR); CRP, C-reactive protein; RF, rheumatoid factor; ESR, Erythrocyte sedimentation rate. 
 
 Baseline values of chromosome aberration types in PBL of the RA patients were 
assessed and presented in Table 2. Numeric chromosomal aberration frequencies of in PBL were 
higher in all RA patient groups when compared to controls, but the only significant difference 
was obtained for the long term active disease patients (P˂ 0.05). There were no structural 
aberrations detected, observing numerical aberrations which included endoreduplications, 
trisomies of chromosomes from the C group and monosomies of chromosomes from the D 
group.  
 The frequency of PCD and incidence of acrocentric chromosomes associations, as 
cytogenetic anomalies resulting from the cell’s response to adverse effects were also measured. 
While PCD frequencies showed no difference when compared to controls, acrocentric 
associations were considerably higher in all RA patients groups. Acrocentric associations were 
higher in active disease groups (EAc MTX, EAc MTX+DOLE and LtAc MTX+DOLE) than in 
long-term patients with low disease activity (LtLa MTX+DOLE) (Table 2). The highest 
frequencies of all chromosome alterations were found in long-term active RA patients. 
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Table 2. Cytogenetic analysis of baseline chromosomal aberrations in human peripheral blood lymphocytes 
in RA patient groups and controls                     
                
Group 
Frequency of numerical 
aberrations / 50 metaphases 
AA Partial PCD Complete PCD 
Controls n=10 0.8 (0.2) 4.5 (0.8) 1.7 (0.6) 0 
EAc MTX n=8 2.2 (1.2) 18.8 (3.8)* 2.8 (0.7) 1.1 (0.1) 
EAc MTX+DOLE n=8 1.7 (0.9) 17.9 (4.6)* 2.1 (0.9) 0 
LtLa MTX+ DOLE n=8 2.0 (0.9) 11.7 (3.6)* 1.0 (0.9) 0 
LtAc MTX + DOLE n=8 4.0 (1.4)* 30.1 (8.6)* 2.1 (0.2) 0.7 (0.0) 
A 50 metaphases per donor were analyzed for the frequency of chromosomal aberrations (CA) including all types of 
numerical chromosome aberrations, associations of acrocentric chromosomes (AA), and partial and complete premature 
centromere division (PCD): partial PCD- in 1 or 2 individual chromosomes; compete PCD- with 50-100 % chromosomes 
with PCD per metaphase; Values are presented as mean (standard deviation, SD), unless otherwise specified. *P˂ 0.05, 
differences between the control and experimental RA groups by Mann Whitney U test. 
Micronuclei are observed in binuclear cells in form of small round shape nuclear bodies 
in cytoplasm not attached to the main nuclei and represent DNA material excess, not 
incorporated into the main nucleus after cell division (Fig. 1B, 2C). Evaluated by micronucleus 
assay, the measure of the chromosome stability changes is the frequency of micronuclei per 1000 
examined binucleated cells. Examples of the observed changes in RA patients binucleated 
lymphocytes in this study are presented in Fig. 1. It is also possible to measure other forms of 
cytogenetic alterations in micronucleus assay, such as nuclear buds (NB) (Fig. 1D) and 
nucleoplasmic bridges (NPB) (Fig. 1E). Apoptotic and necrotic cells were excluded from the 
analysis (Fig. 1F). Frequencies of micronuclei and total aberrant changes (including nuclear buds 
and nucleoplasmic bridges) from cultured RA patients’ human lymphocytes at baseline and at 3 
weeks after treatment are presented in Table 3.  
Results from binucleated cells in cytokinesis block micronucleus assay are shown in 
Table 3. Significantly higher frequencies of micronucleated cells were found at baseline in both 
groups of early active RA patients and in both groups of long-term RA patients (both active and 
low disease activity group) as compared to controls. Significant MN frequency differences were 
found in-between the RA patients’ groups. After the treatment, at 3-week time point, frequencies 
of MN were reduced compared to baseline in the early phase active RA groups, but the 
difference was not significant.  
Speaking about long-term phase RA groups, after 3 weeks of combined treatment, the 
MN frequencies in the long-term patients with low disease activity  did not change, while the 
long-term active phase patients have shown the increased number of MN per 1000 binucleated 
cells as compared to their baseline values, thus being the highest among all RA groups (Table 3). 
Considering frequencies of total aberrant changes in binucleated cells, including nucleoplasmic 
bridges, buds and micronuclei, their values at 3 weeks after treatment were decreased as 
compared to baseline in all experimental groups except for the long-term active phase RA 
patients which remained unchanged. When total aberrant changes frequencies were compared at 
baseline and at 3 weeks after treatment, more pronounced changes were detected in long-term 
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patients with low disease activity than in early phase patients, but those differences were not 
significant due to high variations. 
 
Figure 1. Examples of the lymphocytes scored in the micronucleus assay in rheumatoid arthritis patients: 
A) binucleated cell; B) binucleated cell containing one micronuclei; C) binucleated cell containing 
multiple micronuclei; D) binucleated cell containing nuclear bud; E) binucleated cell with 
nucleoplasmic bridge; F) necrotic cell; 
 
Table 3. Frequencies of micronuclei (MN) in cultured human lymphocytes of rheumatoid arthritis patients 
at baseline and at 3 weeks after treatment, by using cytokinesis-blocked micronucleus assay 
A total of 1000 binucleate cells were scored for micronuclei (MN) per patient and results are pooled as a mean 
value (standard deviation, SD) from all participants in the groups; TA – total aberrations in binucleated cells including 
nucleoplasmic bridges, buds and micronuclei. *P˂0.05, differences between control and experimental RA groups by 
Mann Whitney U test for MN and TA. 
 Frequency MN (pooled) MN range (pooled)     Frequency TA (pooled)       TA range (pooled)     
Groups Baseline                  3 weeks            Baseline      3 weeks   Baseline             3 weeks              Baseline        3 weeks  
Controls 
n=10 
5.7 (3.8) 7.2 (2.6) 1-10 5-11 6.7 (5.1) 8.2 (3.3) 1-13 6-13  
EAc  
MTX 
n=8 
35.3 (18.0)* 24.6 (11.1)* 18-54 16-38 40.3 (32.8) 38.3 (12.5)* 18-79 23-52 
EAc 
MTX+DOLE 
n=8 
33.0 (16.9)* 30.1 (4.9)* 21-45 24-35 42.0 (26.9)* 39.0 (17.0)* 23-74 29-56 
LtLa  
MTX+ DOLE 
n=8 
34.2 (7.9)* 32.6 (18.9)* 21-47 12-49 72.0 (9.0)* 65.6 (26.5)* 63-81 35-82 
LtAc  
MTX+ DOLE 
n=8 
34.3 (8.1)* 47.7 (15.9)* 25-39 34-70 71.0 (11.1)* 73.2 (21.4)* 61-83 52-95 
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DISCUSSION 
The effects of combined Methotrexate and Dry olive leaf extract treatment on 
chromosome instability in rheumatoid arthritis (RA) patients were analyzed with regard to 
disease duration (early and long-term disease RA patients), and to disease activity (active disease 
and low disease activity). Increase in micronuclei or chromosome aberration frequencies 
reflected genomic abnormalities in RA patients peripheral blood lymphocytes, which could be 
positively connected with the active disease phase inflammation process.  
Previous research has shown that activated monocytes/macrophages could increase 
superoxide production in chronic inflammatory diseases, followed by release of long-lived 
metabolites that act as clastogenic factors (EMERIT et al., 1996; FIRESTEIN, 2003). Oxidative 
damage in RA, caused by reduced glutathione levels, was found to induce T-cell 
hyporesponsiveness in synovial fibroblasts, which could be an important therapeutic fact 
(GRINGHUIS et al., 2000). 
Elevated reactive oxygen species (ROS) are established source for DNA damage and 
genomic instability. Increased comet-tail length and MN frequencies, as well as decreased 
antioxidant enzymes superoxide dismutase and glutathione peroxidase levels have already been 
demonstrated in RA patients, in both active and inactive disease period (KARAMAN et al., 2011). 
Elevated DNA damage, related to increased oxidative stress levels, was also correlated with 
disease activity according to JIKIMOTO et al. (2002). Our previous finding has shown increased 
primary DNA damage by comet assay, both in early phase RA patients and in long-term patients, 
the highest damage being demonstrated in the early active stage of the disease (ĈABARKAPA et 
al., 2016).  
Increase in micronucleated cell number is suggestive for chromosome instability. 
Increased micronuclei frequencies in our study have demonstrated presence of genomic damage 
for all experimental RA groups, concordant with other studies, like RAMOS-REMUS et al. (2002) 
and KARAMAN et al. (2011). 
 
Our results of micronuclei frequencies indicated higher damage in 
long-term disease groups than in newly-diagnosed. Total aberrations in cytokinesis-block 
micronucleus assay, including nuclear buds and nucleoplasmic bridges, as well as micronuclei, 
were also significantly higher in long-term RA patients, possibly caused by longer disease 
duration. These aberrant genetic endpoints are positively associated with each other and their 
coincident presence within individual cell suggests common mechanism of generation, either by 
chromosomal damage or structural chromosome rearrangements (CHEONG et al., 2013). 
Increased frequencies of micronuclei could also be explained by other mechanisms, 
apart from chromosome breaks. Micronuclei could also originate from amplified genome 
regions, excluded from the nucleus by a so-called nuclear budding process (IMLE et al., 2009). 
Nuclear budding frequencies were increased in our RA patient groups, indeed. Also, increased 
frequencies of nucleoplasmic bridges were observed, that usually originate from an exchange-
type structural rearrangement (THOMAS et al., 2003). With regard to the above-mentioned 
micronuclei formation in RA patients in our study, it was probably originated from genome 
amplifications and chromosome exchanges, since we did not detect any chromosome breakage in 
lymphocyte cultures. 
At three weeks after the introduction of experimental treatments, decrease in 
micronuclei frequencies were observed in both groups of early phase RA, but not in the long-
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term RA patient groups. However, the changes in micronuclei frequencies were not significant, 
as compared to baseline values in corresponding groups.  
Although DNA damage reduction was observed in our previous study, where all RA 
groups treated with combined DOLE and MTX treatment showed significant improvement in 
DNA damage levels detectable with the comet assay (ĈABARKAPA et al., 2016), the current study 
showed no significant effect of combined treatment on DNA damage levels detectable by 
micronucleus test.  
Differences in DNA damage reduction observed by comet assay in the previous study 
(ĈABARKAPA et al., 2016) and observation by micronucleus test in the current results, could be 
explained by the fact that the comet assay detects DNA damage that originates mostly from the 
single strand breaks (SSB). SSB usually get repaired more quickly and efficiently than the 
double strand breaks (DSB), that are being involved in micronuclei formation (ILIAKIS et al., 
2004; VON SONNTAG, 2006).
 
It is plausible that high level of inflammation in active RA disease 
phase leads to increased oxidative damage levels, mostly presented in the form of DNA single 
strand breaks. If they are not repaired efficiently, two close-by SSBs lead to formation of DSBs, 
and this reaction is largely amplified by the presence of peroxyl radicals (PRISE et al., 1993).
 
Treatment with DOLE may prevent oxidative stress induced formation of SSBs and such 
damage-amplification reactions are thus intercepted. Agents that induce reactive oxygen species 
were also shown to produce error-prone joining of broken DNA strands (BRYANT, 2007). If 
incomplete joining of chromatin ends occur, it would lead to chromosome aberrations. It could 
be suggested that early phase RA patients have more efficient removal of DNA damage than the 
long-term RA patients, concluding that longer disease duration compromise the repair capacity in 
RA patients. This could explain differences in micronuclei reduction between the early and the 
long-term phase patients.  
Considering chromosome aberrations, RA groups have shown numerical aberrations, 
such as endoreduplications, trisomies of chromosomes from the C chromosome group and 
monosomies of the D chromosome group, which are in accordance with previous authors 
findings (KINNE et al., 2001). Endoreduplication is a mitotic manifestation produced after the 
replication of the nuclear genome in the absence of cell division. KINNE et al. (2001) have found 
significant positive correlation between RA patients’ disease duration and levels of polysomies in 
synovial fibroblasts for chromosomes 6 and 8, as well as positive correlation between RA 
collagenase digests levels of polysomy for chromosome 7 and serum CRP concentrations level. 
Together with the results from the present study, results of increased aneuploidies in long-term 
active RA patients indicate a positive link between RA inflammation duration and numerical 
aberration occurrence. Same authors suggested that Methotrexate treatment did not influence 
genomic stability in their study, considering the fact that no correlations were found between the 
polysomy level for any of the chromosomes in RA synovial fibroblasts and methotrexate 
treatment (KINNE et al., 2001). In favor for this assumption, we have found low level of 
aberrations in long-term patients with low disease activity that has been on MTX therapy for 
many years, too.  
Another cytogenetic alteration that should be mentioned is increased frequency of 
acrocentric chromosomes associations (AA) detected in our study, found to be considerably 
higher in all RA patient groups vs controls. Mutual aggregation of acrocentric chromosomes 
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short arms is called satellite association, known to be positively correlated with the degree of 
NOR (Nuclear Organizer Regions) staining (MILLER et al., 1977). NOR are sites of ribosomal 
RNA genes, localized at the second constriction of the acrocentric chromosome. It was shown 
that cells with more rDNA activity and increase of the cell cycle duration would have the 
increased production of AA (REEVES et al., 1982). When DNA damage is increased in the cell, 
damage signal elicits cell cycle arrest, inducing either DNA repair or apoptosis (HUEN and CHEN, 
2008). It is possible that a prolonged cell cycle, due to response to DNA damage, leads to an 
increased occurrence of AA, since the RA groups with the most severe DNA damage have also 
shown the highest frequency of AA. This still remains to be studied in detail by examining of the 
link between DNA damage and cell cycle aberrations in RA patients.  
 
CONCLUSION 
Chromosome instability is increased in patients with early phase rheumatoid arthritis as 
well as with long-term disease, as assessed by the micronucleus test and chromosome aberrations 
evaluation. More pronounced genomic damage was observed in active RA, both in early phase 
and in long-term phase disease than in low disease activity. The results indicate a possible link 
between the cytogenetic alterations and disease duration as well as with disease activity. 
Aggressive inflammatory phenotype in the active RA could induce cytogenetic alterations, such 
as increased frequencies of micronuclei and acrocentric chromosome associations in 
lymphocytes of RA patients. Neither Methotrexate treatment alone nor Methotrexate and Dry 
olive leaf extract combination treatment did significantly affect the levels of cytogenetic 
alteration after three weeks of treatment according to our study; although patients in the early 
phases of the RA disease exhibited some potential for micronuclei reduction after 3 weeks, long-
term RA pathology was much less influenced. 
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Izvod 
Oksidativni stres i inflamacija su faktori u vezi sa pojavom DNK nestabilnosti kod pacijenata sa 
reumatoidnim artritisom (RA). Cilj ove studije je evaluacija citogenetskih promena u limfocitima 
periferne krvi (PBL) kod dve grupe pacijenata sa RA: grupe sa ranim i dugotrajnim RA; kao i 
ispitivanje potencijala kotretmana sa metotreksatom  MTX) i suvim ekstraktom lista maslina 
 DOLE) protiv citogenetskih o tećenja kod pacijenata sa RA nakon tronedeljnog tretmana. U 
studiju je ukljuĉeno ukupno 32 pacijenta, podeljenih u ĉetiri grupe: dve grupe sa ranom fazom 
RA (jedna tretirana samo sa MTX, druga u kombinaciji sa DOLE); i dve grupe pacijenata sa 
dugotrajnim RA (grupa u remisiji i grupa sa aktivnom bole ću) - obe tretirane kombinacijom 
MTX i DOLE. Kulture PBL su pregledane na prisustvo hromozomskih aberacija i odreĊena je 
uĉestalost mikronukleusa. Znaĉajno povi ena uĉestalost mikronukleusa je pokazana kod 
pacijenata u aktivnoj fazi bolesti (ranoj i dugotrajnoj), ali ne i kod grupe pacijenata u fazi 
remisije, u poreĊenju sa kontrolnom. Hromozomske aberacije su zabelezene kod sve ĉetiri grupe 
pacijenata. Najvi a uĉestalost mikronukleusa i hromozomskih aberacija naĊena je kod grupe sa 
dugotrajnom aktivnom fazom RA. Iako su uĉestalosti mikronukleusa smanjene u svim grupama 
sa RA nakon tronedeljnog tretmana u poreĊenju sa poĉetnim vrednostima, grupama, smanjenje 
je bilo znaĉajno samo u grupi sa dugotrajnom aktivnom bole ću. Pokazano je da je visok stepen 
citogenetskog o tećenja kod pacijenata sa RA u vezi sa duzinom trajanja i aktivno ću bolesti. 
Nakon 3 nedelje terapije, ni kombinovani tretman (MTX+ DOLE), niti samostalna primena 
MTX nisu uticali na uĉestalost pojave mikronukleusa.  
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